Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventAug 3, 2015View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 22, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 9, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 6, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 15, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GJun 8, 2015View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 3, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 3, 2015View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-127

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information